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a b s t r a c t
Dengue virus (DENV) non-structural protein 4B (NS4B) has been demonstrated to be an attractive
antiviral target. Due to its nature as an integral membrane protein, NS4B remains poorly characterized.
In this study, we generated and characterized two monoclonal antibodies (mAb) that selectively bind to
DENV NS4B protein. One mAb, 10-3-7, is speciﬁc for DENV-2 NS4B, and its epitope was mapped to
residues 5–15 of NS4B. The other mAb, 44-4-7, cross-reacts with all the four serotypes of DENV NS4B, and
its epitope was mapped to residues 141–147 of NS4B. Using the mAbs, we probed the intracellular
orientation of the epitopes of NS4B by an epitope accessibility assay. The results showed that the N-
terminus of NS4B is located in the ER lumen, whereas amino acids 130–148 of NS4B are located in the
cytosol. The study demonstrates that the two anti-NS4B mAbs will be useful for future structural and
functional analyses of DENV NS4B.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The four serotypes of dengue virus (DENV), primarily transmitted
by Aedes mosquitoes, are the causative pathogen of the mild syn-
drome, dengue fever (DF), and severe syndromes dengue hemorrhagic
fever (DHF)/dengue shock syndrome (DSS) (Halstead, 1988). The global
burden of DENV is huge, with over 2.5 billion people at risk of
infection. Annually, there are about 390 million human infections of
DENV all over the world, leading to 96 million human cases with
manifest symptoms (Bhatt et al., 2013). Despite the unmet medical
need, there is no clinically-approved vaccine or antiviral for prevention
or treatment of DENV infections. Therefore, it is of a great urgency to
develop effective therapies for DENV patients.
Dengue virus belongs to genus Flavivirus within the family
Flaviviridae. Besides DENV, the Flavivirus genus includes yellow fever
virus (YFV), West Nile virus (WNV), Japanese encephalitis virus (JEV),
and tick-borne encephalitis virus (TBEV). The genome of ﬂaviviruses is
a single-strand, plus-sense RNA of 11 kb in length. The genomic RNA
contains 5ʹ un-translated regions (UTR), a long open reading frame
(ORF), and a 3ʹUTR. The ORF encodes a long polyprotein, which is co-
and post-translationally processed into three structural proteins
(capsid [C], pre-membrane [prM], and envelope [E]) and seven
nonstructural proteins (NS1, NS2A/2B, NS3, NS4A/4B, and NS5) by
the viral and cellular proteases (Lindenbach et al., 2007). The structural
proteins are components of virus particles, and play essential roles in
viral entry, fusion and assembly. Nonstructural proteins are respon-
sible for viral RNA replication (Lindenbach et al., 2007), evasion of
innate immune response (Guo et al., 2005), and virus assembly
(Kummerer and Rice, 2002; Xie et al., 2013). Among the ten viral
proteins, only NS3 and NS5 have known enzymatic activities. NS3
contains protease (requiring associationwith NS2B), RNA helicase, and
nucleotide triphosphatase (NTP) activities (Warrener et al., 1993;
Wengler et al., 1991). NS5 contains a methyltransferase activity which
is responsible for viral RNA capping and internal RNA methylation
(Dong et al., 2012; Egloff et al., 2002), and an RNA-dependent RNA
polymerase (RdRp) activity (Ackermann and Padmanabhan, 2001).
Limited information is available about the small hydrophobic mem-
brane proteins NS2A, NS4A, and NS4B. Previous studies showed that
these proteins are integral membrane-associated and span the endo-
plasmic reticulum (ER) membrane with multiple transmembrane
segments (Miller et al., 2006; Miller et al., 2007; Xie et al., 2013).
NS2A is proposed to function in viral replication (Mackenzie et al.,
1998) and assembly (Xie et al., 2013; Leung et al., 2008). NS4A induces
membrane rearrangement for the formation of the replication com-
plex (Miller et al., 2007). DENV NS4B, a 27 kDa hydrophobic protein,
consists of 248 amino acids (Miller et al., 2006; Chambers et al., 1989).
The N-terminal region of NS4B is localized in the endoplasmic
reticulum (ER) lumen, while the C-terminal region contains three
membrane-spanning segments (Miller et al., 2006). Flavivirus
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NS4B is essential for viral replication and for suppression of
interferon-induced JAK/STAT signaling (Munoz-Jordan et al., 2005).
A number of NS4B inhibitors have been reported for potential
antiviral development (Xie et al., 2011; van Cleef et al., 2013;
Patkar et al., 2009). Due to the fact that it is an integral membrane
protein, NS4B remains hitherto poorly characterized. Reagents, such
as monoclonal antibodies (mAb), are critically needed to characterize
the function of ﬂavivirus NS4B.
In this study, we generated and characterized two monoclonal
antibodies (mAbs clones: 10-3-7 and 44-4-7). MAb 10-3-7 was
identiﬁed to be highly speciﬁc for the NS4B protein of DENV-2. Its
epitope was mapped to the N-terminal amino acids 5–15 of NS4B.
MAb 44-4-7 cross reacts with the NS4B proteins of all four serotypes
of DENV and of WNV. Its epitope was mapped to amino acids 141–
147 of NS4B. The antibodies were used to validate the membrane
topology of NS4B. To the best of our knowledge, this is the ﬁrst report
on the development of a monoclonal anti-NS4B antibody. The
development of these antibodies provides critical biological reagents
for future structural and functional analyses of DENV NS4B.
Results
Generation of anti-NS4B mAbs
The DENV-2 NS4B was expressed in E. coli., isolated from
membrane fractions, and reconstituted into 0.03% n-Dodecyl β-D-
maltopyranoside (DDM) micelles. The recombinant DENV-2 NS4B
was used to immunize BALB/c mice for antibody production. The
speciﬁc antibody titer during immunization was monitored by
analyzing blood samples using an indirect ELISA as described in the
Materials and Methods. Spleenocyte fusion was carried out when the
antibody titer reached 41:6400, followed by limiting dilution
cloning and screening. A total of 58 hybridoma cultures were positive
in the primary ELISA screen (data not shown), among which tenwere
chosen for two more rounds of cloning to stabilize the cell line and to
ensure the monoclonality of the hybridomas. Two stable clones
(clones 10-3-7 and 44-4-7) were obtained for further characteriza-
tion. Analysis of the supernatants derived from the two hybridomas
by an indirect ELISA showed that they contained antibodies with
high speciﬁcity for recombinant NS4B protein (Fig. 1A). Isotyping
showed that clone 10-3-7 produced IgG1 antibody, while clone 44-4-
7 produced IgG2b antibody. We therefore used protein-G afﬁnity
chromatography to purify the antibodies from serum-free hybridoma
supernatants for further studies.
Western blot analysis showed that both antibodies bound to
recombinant DENV NS4B with an estimated molecular mass of
28 kDa (Fig. 1B, lanes 1 and 5). The antibodies also bound to the
NS4B protein derived from the BHK-21 DENV-2 replicon cell (BHK-21
Rep cell) lysates (with a calculated molecular mass of 27.3 kDa but
with an apparent mobility of 25 kDa; Fig. 1B, lanes 2 and 6). The
discrepancy in molecular mass between the recombinant NS4B and
the replicon cell-derived NS4B is due to an extra decahistidine tag
fused to the N-terminus of the recombinant NS4B protein. No bands
were detected when naive BHK21 cell lysates (without replicon)
were analyzed as negative controls (Fig. 1B, lanes 3 and 7). Interest-
ingly, mAb 44-4-7, but not mAb 10-3-7, bound to recombinant WNV
NS4B protein (Fig. 1B, lanes 4 and 8).
Next, IFA was performed to examine the antibody speciﬁcity
using DENV-2 BHK-21 Rep cells. Fig. 1C (left panels) shows that the
Fig. 1. Generation and characterization of anti-NS4B mAbs. (A) Reactivity of two hybridomas to DENV-2 NS4B by ELISA. Hybridoma supernatants were tested for the
presence of antibodies in an indirect ELISA using plate coated with recombinant DENV-2 NS4B protein. The culture supernatants of SP2/0-Ag14 myeloma cells were used as
the negative control (N.C.). (B) Reactivity of two hybridomas to DENV-2 NS4B and WNV NS4B by Western blot. Lanes 1 and 5, recombinant DENV-2 NS4B protein; Lanes
2 and 6, BHK-21 Rep cell lysates; Lanes 3 and 7, naive BHK-21 cell lysates; Lanes 4 and 8, recombinant WNV NS4B protein. (C) Reactivity of two hybridomas to DENV-2 NS4B
by IFA. BHK-21 Rep cells or naive BHK-21 cells were seeded in chamber slides. After 24 h incubation, the cells were ﬁxed and permeabilized for immunoﬂuorescence staining.
The DENV NS4B was detected with Alexa Fluor488 (green) while the cell nuclei were stained with DAPI (blue).
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mAbs 10-3-7 and 44-4-7 recognize the native NS4B expressed in
the DENV-2 replicon cell line. Naive BHK21 cells did not display
any IFA-positive signals (right panels). Collectively, the Western
blot and IFA results demonstrate the speciﬁcity of the two NS4B
antibodies.
Cross-reactivity of anti-NS4B mAbs
The cross-reactivity of the two antibodies against NS4B protein
derived from four serotypes of DENV was examined. BHK-21 cells
were infected with individual serotypes of DENV (DENV-1 strain
Westpac; DENV-2 strain New Guinea C; DENV-3 strain H87, and
DENV-4 strain H241) at an MOI of 2. At 48 h post-infection, the
cells were ﬁxed and examined for NS4B expression by anti-NS4B
mAbs. The cross-reactive antibody 4G2 against E protein was used
as a positive control. MAb 44-4-7 recognized all four serotypes of
DENV NS4B proteins, whereas mAb 10-3-7 detected only DENV-2
NS4B (Fig. 2A). The cross-reactivity of anti-NS4B mAbs was further
validated by Western blot using DENV infected BHK-21 cell lysates.
Consistent with the immunoﬂuorescence analysis, mAb 10-3-7
reacted only with DENV-2 NS4B; while mAb 44-4-7 reacted with
the NS4B of all four serotypes (Fig. 2B). The results demonstrate
that mAb 10-3-7 is speciﬁc to DENV-2 NS4B, whereas mAb 44-4-7
is reactive to all four serotypes of DENV NS4B.
Epitope mapping of anti-NS4B mAbs by peptide microarrays
The epitopes for the anti-NS4B mAbs were identiﬁed by peptide
microarray immunoassay (Perez-Gordo et al., 2012). A library of 60
overlapping 15-mer peptides corresponding to full-length NS4B
(residues 1–248) of DENV2 strain TSV01 was synthesized and
immobilized on microarray slides. The peptide microarray was
incubated with or without (as a negative control) anti-NS4B mAb
followed by detection with ﬂuorescently labeled goat anti-mouse
IgG (H&L). The ﬂuorescence intensity was measured to identify
epitope peptides that bound to the mAbs. As shown in Fig. 3B, the
epitope for mAb 10-3-7 was mapped to the N-terminal amino
acids 5–15 of NS4B (peptides F1 and F2, Fig. 3A), while the epitope
of mAb 44-4-7 was mapped to amino acids 141–147 (peptides F34,
F35, and F36), located in the cytosolic loop of NS4B (Miller et al.,
2006). Interestingly, mAb 44-4-7, but not 10-3-7, lost its ability to
detect a transiently-expressed 2K-NS4B mutant protein, which
contained a lysine at position 143 instead of serine (data not
shown), strongly supporting the mapping results.
Fig. 2. Cross-reactivity of anti-NS4B mAbs. BHK-21 cells were infected with DENV-1 to 4 at an MOI of 2. At 48 h post infection, the cells were harvested and analyzed by IFA
(A) or Western blotting (B). Blue, DAPI; green, NS4B or Env protein. Lane 1, DENV-1 infected cell lysates; lane 2, DENV-2 infected cell lysates; lane 3, DENV-3 infected cell
lysates; lane 4, DENV-4 infected cell lysates. The arrow indicates bands of the expected size.
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Amino acid sequence alignment among the four serotypes of
DENV NS4B and WNV NS4B showed that: (i) for the epitope of mAb
44-4-7, residues 141–144 and 147 are fully conserved (Fig. 3C);
(ii) for the epitope of mAb 10-3-7, there are only four conserved
residues (Glu7, Thr9, Lys10 and Asp12) within the residues 5–15
(Fig. 3C). The degree of sequence conservation supports the
observation that mAb 44-4-7 binds to all four serotypes of DENV
NS4B and to WNV NS4B, whereas mAb 10-3-7 speciﬁcally binds
DENV-2 NS4B (Figs. 1B, and 2A, B).
Thermodynamic characterization of epitope binding to NS4B mAbs
by ITC
To further conﬁrm the epitope(s) of the two NS4B mAbs, we
determined their binding thermodynamics by isothermal titration
calorimetry (ITC). We synthesized a panel of peptides corresponding
to the N-terminal 15 amino acids and residues 130–167, 130–148,
149–167, 142–156, and 156–170. Each peptide was tested for its
binding afﬁnity to the mAbs using ITC. The binding of the peptides to
the corresponding mAb was driven entirely by a favorable enthalpy,
with an unfavorable entropy upon binding. MAb 10-3-7 bound with
high afﬁnity to the peptide corresponding to residues 1–15 of NS4B
(Figs. 3A and 4, left panel), but no binding was detected to the other
peptides (data not shown), indicating that the antibody speciﬁcally
recognizes the N-terminus of NS4B. MAb 44-4-7 bound with high
afﬁnity to peptides 130–148 (Fig. 4, middle panel) and 130–167
(Fig. 4, right panel), but no binding was detected to peptides 149–167
or 142–156 (data not shown), conﬁrming that mAb 44-4-7 binds to
residues 130–148, within the cytosolic loop of NS4B (Fig. 3A). The
binding titrations ﬁt closely to a stoichiometry of one antibody to two
peptides, as expected for a bivalent antibody.
Subcellular localization of epitopes recognized by NS4B mAbs
It was proposed that the N-terminal part of NS4B is localized in
the ER lumen, whereas the C-terminal part contains three trans-
membrane domains with one cytosolic loop (Miller et al., 2006).
To validate the topology model in the context of viral infection,
we used the two anti-NS4B mAbs to probe the orientation of the
N-terminus and cytosolic loop of NS4B by an epitope accessibility
assay (Otto and Smith, 1994). BHK-21 cells were infected with
DENV-2 strain NGC at an MOI of 0.5. At 24 h post-infection, the
cells were ﬁxed with paraformaldehyde, and permeabilized with
low concentrations of digitonin or Triton X-100. Since digitonin
permeabilizes only the plasma membranes, and Triton X-100
permeabilizes both the plasma and internal membranes, we could
Fig. 3. Epitope mapping of anti-NS4B mAbs. (A) Peptides used in peptide microarray (black lines) and ITC (red lines) studies. The NS4B sequence is from DENV-2 strain TSV01
with predicted transmembrane regions (TMD) indicated as gray boxes. (B) Epitope mapping by a peptide microarray. The microarray plates were coated with synthesized
peptides and used for screening by mAbs 10-3-7 and 44-4-7. The wells incubated with ﬂuorescently labeled secondary antibody only were performed as controls to detect
potentially false positives signals. The mean values of ﬂuorescence intensities derived from the microarray screening are shown. (C) Alignment of the amino acids 1–16 and
133–155 of DENV-2 NS4B and WNV NS4B. The highlighted regions (4–14; 141–147) indicate the epitopes recognized by the mAbs. The dots indicate the conserved residues
among four serotypes of DENV and WNV.
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use mAbs to determine the subcellular localization of the NS4B
epitopes (either in the ER lumen or cytoplasm) upon immunos-
taining. A rabbit polyclonal antibody (H-70) speciﬁcally targeting
the ER luminal domain of calnexin was used as a control. As shown
in Fig. 5A, when probed by mAb 10-3-7, the NS4B protein could
only be detected in the infected cells treated with Trion X-100,
revealing a staining pattern similar to that of calnexin. This result
suggests that the epitope recognized by mAb 10-3-7 (the
N-terminal 15 residues of NS4B) resides in the ER lumen
(Fig. 5C). In contrast, when probed by mAb 44-4-7, NS4B protein
was detected in the infected cells permeabilized with both Triton
X-100 and digitonin (Fig. 5B), indicating that the epitope (residues
133–155 of NS4B) resides in cytosol (Fig. 5C). Taken together, these
results support the current topology model of DENV NS4B.
Discussion
All ﬂaviviral proteins, including NS4B, are potential targets for
antiviral therapy. Due to the hydrophobic nature of the NS4B protein,
puriﬁcation of the recombinant NS4B protein for generation of
highly-speciﬁc antibodies is challenging. We have overcome this
challenge by developing a method to purify recombinant DENV-2
NS4B protein, allowing the generation of two monoclonal antibodies
(mAbs 10-3-7 and 44-4-7) using a standard hybridoma technology.
By immunoﬂuorescence and Western blot analyses, we found that
these two antibodies speciﬁcally react with recombinant NS4B
protein, NS4B expressed in DENV replicon cells, and NS4B expressed
in DENV-infected cells. Both mAbs were able to bind to native and
denatured NS4B protein. Using a peptide microarray immunoassay
and ITC analysis, we mapped the epitope of mAb 10-3-7 to the
N-terminus of the NS4B, and the epitope of mAb 44-4-7 to the
cytosolic loop of the protein. Sequence alignment of the four
serotypes of DENV NS4B and WNV NS4B showed a high degree of
amino acid variation in the epitope of mAb 10-3-7, explaining the
speciﬁcity of this mAb for DENV-2; in contrast, the amino acids in the
epitope of mAb 44-4-7 are highly conserved, accounting for a broadly
cross-reactivity of this mAb to all four serotypes of DENV NS4B and
WNV NS4B.
The development of the NS4B mAbs allowed us to probe the
subcellular localization of the NS4B epitopes in situ. The in situ
localization result conﬁrms the current model of NS4B membrane
topology.
In summary, we have generated and characterized two novel and
highly-speciﬁc mAbs against DENV NS4B. These mAbs have already
been shown to be useful for detection by immunoﬂuorescence
microscopy, making them valuable tools in cell biology study.
Furthermore, crystallization of the membrane protein complexed
with Fab or Fv fragments derived from monoclonal antibodies has
allowed structure determination for ion channels, G-protein coupled
receptors, and membrane transporters (Hunte and Michel, 2002).
These NS4B mAbs may therefore be of particular importance for
crystallization of NS4B protein for high-resolution structural studies.
Materials and methods
Cells, viruses and antibodies
Baby hamster kidney (BHK-21) cells were obtained from American
Type Culture Collection (ATCC), and maintained in a high glucose
Dulbecco modiﬁed Eagle medium (DMEM) (Invitrogen, Carlsbad, CA)
supplemented with 4 mM L-glutamine, 10% fetal bovine serum (FBS)
(HyClone Laboratories, Logan, UT), and 1% penicillin/streptomycin
(Invitrogen, Carlsbad, CA). DENV-2 replicon cell line (Zou et al.,
2011) was maintained in the above complete DMEM medium
containing 1 mg/ml G418 (Invitrogen, Carlsbad, CA). The following
viruses were used: DENV-1 (strain Westpac), DENV-2 (strain New
Guinea C), DENV-3 (strain H87) and DENV-4 (strain H241). DENV
speciﬁc mouse monoclonal antibody 4G2 against envelope protein
was prepared from hybridoma cell line purchased from ATCC. A
rabbit polyclonal IgG against Calnexin (H-70) was purchased from
Santa Cruz Biotechnology. A rabbit polyclonal IgG against DENV-2
NS1 was purchased from Genetex.
Expression and puriﬁcation of recombinant NS4B protein
The detailed expression and puriﬁcation protocol will be
published elsewhere (Zou et al., in press). Brieﬂy, the cDNA of
Fig. 4. Calorimetric titrations of anti-NS4B mAbs with epitope peptides. The determined thermodynamic parameters and the sequences of the epitope peptides are shown in
the tables.
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the full-length NS4B of DENV-2 strain TSV01 was cloned into
pET28a, and the plasmid was transformed into E. coli BL21 (DE3)
for expression. The cell lysates were centrifuged to pellet mem-
branes which were further solubilized with 1% n-dodecyl-β-D-
maltopyranoside (DDM) (Anatrace). After removing the insolubi-
lized fractions by ultracentrifugation, the supernatants were
puriﬁed in two steps by metal-afﬁnity puriﬁcation followed by
gel ﬁltration on a HiLoadSuperdex 200 16/60 column. The cDNA of
E2-K254 of the NS4B protein of WNV NY-99 strain was cloned into
pNIC28-Bsa4. The expression and puriﬁcation of the WNV NS4B
protein followed a similar protocol as that of the DENV NS4B
protein described above.
Generation of mAbs
Recombinant DENV-2 NS4B proteins were used for generation
of monoclonal antibodies by BioGenes GmbH (Berlin, Germany)
following a standard mouse ascites method. Brieﬂy, three BALB/c
mice (female, 8 weeks old) were immunized intraperitoneally
with NS4B emulsiﬁed in Freund0s complete adjuvant over 39 days.
After the immunization period, the spleens were aseptically
removed, pooled and homogenized. The splenocytes were fused
with SP2/0-Ag14 myeloma cells using 50% (v/v) polyethylene
glycol 3350 (SIGMA). The hybridomas were diluted into complete
DMEM supplemented with 20% fetal calf serum (FCS) and
Fig. 5. Determination of the subcellular localization of epitopes recognized by anti-NS4B mAbs. BHK-21 cells were infected with DENV-2. Cells were ﬁxed at 24 h post
infection and permeabilized with 0.1% Trion X-100 or 20 mM digitonin for 10 min at room temperature for subsequent immunoﬂuorescence staining. The DENV NS4B was
detected with Alexa Fluor488 (green). The ER-resident protein, calnexin, was detected with Alexa Fluor594 (red). The cell nuclei were stained with DAPI (blue). (C) Schematic
diagram of location of anti-NS4B antibody epitopes. The membrane topology model is adapted from (Miller et al., 2006).
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hypoxanthine–aminopterin–thymidine (HAT) medium and then
plated out in eight 96-well plates pre-coated with peritoneal
exudate cells as feeder cells. Hybridoma cell culture supernatant
was tested for antibody production by an indirect enzyme-linked
immunosorbent assay (ELISA). Cells from wells with positive
culture supernatant were cloned by limiting dilution. MAbs were
afﬁnity puriﬁed with protein G Sepharose and stored in phosphate
buffered saline (PBS) (pH 7.4) containing 0.02% NaN3.
Enzyme-linked immunosorbent assay (ELISA)
A 96-well plate was coated with 50 ml/well of DENV-2 NS4B at
2 mg/ml in 0.1 M carbonate/bicarbonate buffer (pH 9.6) at 4 1C over-
night. After three washes with a washing buffer (10 mM Tris [pH7.8],
200 mM NaCl and 0.05% Triton X-100), the wells were blocked in a
blocking buffer (2% FCS in TBS) for 1 h at room temperature. Serial
diluted hybridoma culture supernatants were added to the plates
and incubated at room temperature for 1 h. SP2/0-Ag14myeloma cell
culture supernatant and a 1:100 dilution of the serum pool of mice
used for hybridoma production were tested in parallel as negative
and positive assay controls, respectively. After three washes with
washing buffer, the plates were incubated with goat anti-mouse
IgG conjugated to alkaline phosphatase (Sigma) (1:5000 diluted in
blocking buffer) at room temperature for 1 h. The plates were
washed again and the alkaline phosphatase activity was measured
in substrate buffer (2 mM 4-nitrophenylphosphate in 5% diethanola-
mine, 1 mM MgCl2, pH 9.8) by reading the optical density at 405 nm
(OD405 nm) using a Dynex Opsys MR microplate reader. Wells with
OD405 nm values two-fold higher than the average plate OD405 nm
were considered as positive wells.
SDS-PAGE and Western blot analysis
BHK-21 cells were individually infected with four serotypes of
dengue viruses (MOI about 2.0) at 30 1C. At 48 h post infection, cells
were harvested and lysed in RIPA buffer followed by centrifugation at
20,000g for 15 min. The supernatants were collected and heated at
95 1C for 10 min in LDS sample buffer containing DTT prior to SDS-
PAGE analysis. Proteins were transferred onto a PVDF membrane
using a Trans-Blots Turbo™ Transfer System (Bio-Rad) followed by
incubation in blocking buffer (5% skim milk, 20 mM Tris–HCl [pH
7.5], 137 mM NaCl, and 0.1%Tween-20) for 1 h. The blots were
incubated in blocking buffer containing corresponding antibodies
against NS4B or NS1 (1:1000 dilution) overnight at 4 oC. After three
washes with TBST buffer, the blots were incubated with a goat anti-
mouse or anti-rabbit antibody conjugated to horse radish peroxidase
(1:30,000 dilution) in blocking buffer for 1 h. After extensive washes,
the antibody-protein complexes were detected using the Amersham
ECL Prime Western Blotting Detection Reagent (GE healthcare).
Immunoﬂuorescence assay (IFA)
BHK-21 cells infected with four serotypes of dengue viruses
were grown in an 8-well Lab-Tek II chamber slide (Thermo Fisher
Scientiﬁc). The infected cells were ﬁxed in PBS supplemented with
4% paraformaldehyde at room temperature for 20–30 min, per-
meabilized with either 0.1% (v/v) Triton X-100 or 20 mM digitonin
in PBS for 10 min, and blocked with PBS containing 5% FBS or 1%
bovine serum albumin (BSA). DENV NS4B protein was detected
using the monoclonal antibodies generated in the study, and NS1
protein was detected with anti-NS1 antibody. Secondary antibo-
dies used were Alexa Fluors 488 goat anti-mouse IgG or Alexa
Fluors 594 goat anti-rabbit IgG (1:1000) (Invitrogen, Carlsbad,
CA). Chamber slides were mounted in a Vectashield (Hard-Set with
DAPI) and labeling was observed on a Leica DM4000 B system.
Images were merged using Adobe Photoshop CS3 software.
Epitope mapping of mAbs using peptide microarrays
A library of 15-mer peptides derived from the NS4B sequence
of DENV-2 (strain TSV01) was synthesized and printed onto
RepliTope™ peptide microarray slides (JPT Peptide Technologies,
Berlin, Germany). The coated microarrays were processed on an
automated TECAN HS400 microarray processing station using
anti-NS4B mAbs (1 mg/ml) as the primary antibody and a goat anti-
Mouse IgG (H&L) conjugated with DyLight 650 (Thermo Scientiﬁc)
as the secondary antibody. Microarrays were scanned using a high
resolution ﬂuorescence scanner (Axon Genepix Scanner 4300A) and
the data were analyzed by the spot-recognition software GenePix.
Isothermal titration calorimetry (ITC) analysis
Isothermal titration calorimetry (ITC) experiments were per-
formed on an ITC200 system (GE Healthcare). The antibody was
dialyzed into 20 mM Tris–HCl, pH 7.5, 150 mM NaCl. Peptides,
purchased from AAT Bioquest as lyophilized powders, were dis-
solved in the same buffer. Titrations were performed at 25 1C with
150–300 mM peptide in the syringe and 5–15 mM antibody in the
cell. The antibody concentration was calculated by assuming an
A280, extinction coefﬁcient of 210,000 M1 cm1. Typically an
initial injection of 0.2 ml was followed by 15 injections of 2.6 ml.
Control experiments to determine the heat of dilution of the
peptides into buffer were performed in the same way and
subtracted from the peptide-antibody titrations. The data were
ﬁtted to a 1:1 binding model using Origin.
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